Inventor · disambiguated record
Alfred Arthur Rabow
Also filed as: RABOW ALFRED ARTHUR
9 granted patents·4 pending applications·26 citations·filing 2008–2022
85Inventor score
Top patents by PatentIndex Score
13 records- 0186US9944650B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2015·Granted Apr 17, 2018·5 cites·8 claims
- 0283US10766905B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2019·Granted Sep 8, 2020·1 cites·8 claims
- 0383US10407432B2[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2018·Granted Sep 10, 2019·3 cites·8 claims
- 0480US9155727B2Chemical compoundsASTRAZENECA AB·Filed 2014·Granted Oct 13, 2015·5 cites·11 claims
- 0579US8003649B2Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155ASTRAZENECA AB·Filed 2008·Granted Aug 23, 2011·4 cites·15 claims
- 0675US8258140B2Chemical compounds—643BRADBURY ROBERT HUGH·Filed 2010·Granted Sep 4, 2012·8 cites·8 claims
- 0770US2023035133A1[1,2,4]Triazolo[4,3-B]Pyridazines For Use in the Treatment of Proliferative DiseasesASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 0866US11407755B2[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseasesASTRAZENECA AB·Filed 2020·Granted Aug 9, 2022·0 cites·15 claims
- 0957US10130617B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Nov 20, 2018·0 cites·13 claims
- 1056US2019038607A1Chemical compoundsASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 1154US9616050B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted Apr 11, 2017·0 cites·8 claims
- 1239US2013203714A1Chemical compounds - 643BRADBURY ROBERT HUGH·Filed 2012·Application pending·0 cites
- 1335US2010292222A1Chemical compounds 751ASTRAZENECA AB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alfred Arthur Rabow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →